Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
134.46
+7.06 (5.54%)
At close: Feb 27, 2026, 4:00 PM EST
134.99
+0.53 (0.39%)
After-hours: Feb 27, 2026, 7:54 PM EST
Illumina Revenue
In the year 2025, Illumina had annual revenue of $4.34B, down -0.66%. Illumina had revenue of $1.16B in the quarter ending December 28, 2025, with 4.98% growth.
Revenue (ttm)
$4.34B
Revenue Growth
-0.66%
P/S Ratio
4.73
Revenue / Employee
$430,853
Employees
10,080
Market Cap
20.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 4.34B | -29.00M | -0.66% |
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | Pro | Pro | Pro |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 7.07B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
| Revvity | 2.86B |
ILMN News
- 1 day ago - Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - PRNewsWire
- 2 days ago - Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026 - Business Wire
- 3 days ago - Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics - PRNewsWire
- 4 days ago - Illumina launches TruPath Genome, setting a new standard in genomic insight - PRNewsWire
- 5 days ago - Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - PRNewsWire
- 11 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 12 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 23 days ago - Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript - Seeking Alpha